Risk factor management after myocardial infarction: Reported adherence and outcomes

American Heart Journal

Volumn 157, Issue 3, 2009, Pages 556-562

  Decker, Carole ^a,b   Ahmad, Homaa ^c   Moreng, Kate Louise ^b   Maddox, Thomas M ^d   Reid, Kimberly J ^a   Jones, Philip G ^a   Spertus, John A ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NITRATE; WARFARIN;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; HEALTH STATUS; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SECONDARY PREVENTION;

AGED; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PATIENT DISCHARGE; RISK FACTORS; TREATMENT OUTCOME;

EID: 60749125439     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.022     Document Type: Article

References (34)

1. Aldana S.G., Whitmer W.R., Greenlaw R., et al. Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation. Heart Lung 32 (2003) 374-382
2. Ornish D., Scherwitz L.W., Billings J.H., et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280 (1998) 2001-2007
3. American Heart Association. Available at: http://americanheart.org/downloadable/heart/1140534985281Statsupdate06bo ok.pdf. Last accessed September 18, 2006.
4. Makaryus A.N., and Friedman E.A. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc 80 (2005) 991-994
5. Hayes K.S. Literacy for health information of adult patients and caregivers in a rural emergency department. Clin Excell Nurse Pract 4 (2000) 35-40
6. Sdringola S., Nakagawa K., Nakagawa Y., et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 41 (2003) 263-272
7. Smith Jr. S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
8. Bradley E.H., Herrin J., Elbel B., et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA 296 (2006) 72-78
9. Joint Commission. Available at: http://www.jointcommission.org. Last accessed January 21, 2008.
10. Spertus J.A., Peterson E., Rumsfeld J.S., et al. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)-evaluating the impact of myocardial infarction on patient outcomes. Am Heart J 151 (2006) 589-597
11. Ware Jr. J., Kosinski M., and Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
12. Spertus J.A., Winder J.A., Dewhurst T.A., et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 25 (1995) 333-341
13. Spertus J.A., Winder J.A., Dewhurst T.A., et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 74 (1994) 1240-1244
14. Spertus J.A., Jones P., McDonell M., et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 106 (2002) 43-49
15. Spertus J., Decker C., Woodman C., et al. Effect of difficulty affording health care on health status after coronary revascularization. Circulation 111 (2005) 2572-2578
16. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
17. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
18. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. Am Heart J 139 (2000) 1-9
19. Rahimi A.R., Spertus J.A., Reid K.J., et al. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA 297 (2007) 1063-1072
20. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 4th ed Rev (1994), American Psychiatric Association, Washington, DC
21. Vaglio Jr. J., Conard M., Poston W.S., et al. Testing the performance of the ENRICHD social support instrument in cardiac patients. Health Qual Life Outcomes 2 (2004) 24
22. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004) 702-706
23. Harrell F.E. Regression modeling strategies with applications to linear models, logistic regression and survival analysis (2001), Springer-Verlag, New York
24. R version 2.6.0 (R Development Core Team). R: a language and environment for statistical computing (2006), R Foundation for Statistical Computing, Vienna, Austria
25. Lunceford J.K., and Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 23 (2004) 2937-2960
26. Conn V.S., Taylor S.G., and Abele P.B. Myocardial infarction survivors: age and gender differences in physical health, psychosocial state and regimen adherence. J Adv Nurs 16 (1991) 1026-1034
27. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 19 (2006) 1190-1196
28. Lavigne M., Rocher I., Steensma C., et al. The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Public Health 6 (2006) 66
29. Ades P.A. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345 (2001) 892-902
30. Williams M.A., Ades P.A., Hamm L.F., et al. Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J 152 (2006) 835-841
31. Thomas R.J., King M., Lui K., et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons. J Am Coll Cardiol 50 (2007) 1400-1433
32. Sundararajan V., Bunker S.J., Begg S., et al. Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998. Med J Aust 180 (2004) 268-271
33. Roman O., Gutierrez M., Luksic I., et al. Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study. Cardiology 70 (1983) 223-231
34. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497